Supplement
Curcumin
Turmeric's active compound. Strongest case is joint pain; everything else is promising but thinner.
Curcumin is the main bioactive polyphenol in turmeric root (roughly 2 to 9 percent of the dried root). We grade Curcumin B on evidence and B+ for worth-it at about $15-30 per month.
Evidence
Worth it
Typical cost: $15-30/month
What it does
Curcumin is the main bioactive polyphenol in turmeric root (roughly 2 to 9 percent of the dried root). It is studied as an anti-inflammatory and antioxidant. A critical caveat runs through all the evidence: plain curcumin is poorly absorbed, so trials use standardized extracts, often paired with piperine (black pepper extract) or in enhanced-delivery forms. Turmeric powder from the spice rack does not reach studied doses.
What the research says
Reduces knee osteoarthritis pain and improves function
Evidence: moderate. Systematic reviews and meta-analyses of RCTs; one 4-week head-to-head trial found a turmeric extract comparable to ibuprofen on pain and function, with fewer stomach complaints. Common effective dose around 1,000 mg curcumin/day.
Speeds recovery after hard exercise (less soreness, lower creatine kinase and IL-6)
Evidence: moderate. 2024 PLOS ONE meta-analysis: 14 RCTs, 349 participants. Doses 150-1,500 mg/day; enhanced-absorption forms work at the lower end.
Improves blood lipids (triglycerides and LDL down, HDL up)
Evidence: moderate. 2025 systematic review and meta-analysis (2010-2025): pooled TG -25.5, LDL -17.0, HDL +5.7 mg/dL across small RCTs; piperine combo outperformed turmeric alone.
Lowers fasting blood sugar and insulin-resistance markers
Evidence: moderate. 2024 umbrella review of 103 RCTs reported high-credibility evidence on fasting blood sugar, moderate on HOMA-IR and insulin.
Eases depressive symptoms as an adjunct
Evidence: emerging. 2014 RCT (n=60): 500 mg twice daily performed comparably to fluoxetine 20 mg over 6 weeks; 2025 systematic review supports adjunct use. Small trials; never a reason to stop prescribed medication.
Supports memory in older adults
Evidence: emerging. Single 18-month UCLA RCT (n=40): 90 mg Longvida curcumin twice daily improved memory scores and reduced amyloid/tau on PET. Needs replication.
Large RCT base for a supplement (100+ trials in umbrella reviews) with the strongest signal in knee osteoarthritis pain and post-exercise recovery. Heterogeneous trial quality, small samples in several areas, and the bioavailability caveat keep it below A.
What the experts say
Every position links to its source. We include skeptics alongside supporters.
Derek (More Plates More Dates)
“taking 1,200 milligrams of curcumin daily”
Source Takes 1,200 mg daily as part of his health-support list.
Rhonda Patrick
“I take curcuma zorb from Pure Encapsulations. Which is the Meriva. So it's a curcumin phytosome, which is more bioavailable.”
Source Takes a curcumin phytosome (Meriva) supplement for its anti-inflammatory effects, citing clinical studies showing lowered inflammatory biomarkers.
Kathryn Nelson
“curcumin is an unstable, reactive, nonbioavailable compound and, therefore, a highly improbable lead.”
Source, 2026-06-01 Critical; her 2017 Journal of Medicinal Chemistry review concluded curcumin is an unstable, reactive, nonbioavailable compound and a highly improbable therapeutic lead.
Bryan Johnson
Source, 2026-03-24 Takes 1 gram of turmeric (curcumin) at dinner and again before bed as an anti-inflammatory for brain and joint health.
Is it worth it?
Inexpensive (roughly $15-30/month) with a real evidence base for joint pain and recovery. Good evidence per dollar for those use cases.
Typical cost
$15-30/month
Common form, not a brand recommendation
Dosage contextestablished
500-1,000 mg/day of standardized curcumin extract is the common trial range; bioavailability-enhanced forms (with piperine, Meriva, BCM-95, Longvida) are effective at lower doses. Whole turmeric powder does not reach studied doses.
Safety notes
Generally well tolerated. Possible GI upset at high doses. Caution with anticoagulant or antiplatelet drugs (theoretical bleeding risk). May inhibit DHT synthesis (libido caution, per Huberman). Commercial turmeric powders have had lead-contamination issues; use tested extracts. May blunt training adaptations if dosed around workouts.
Longevity Lab Report
Curcumin news, graded when it happens.
New studies, dose debates, and expert shifts on curcumin, in one email a week. Free.
Changelog
Last updated 2026-10-15
- 2026-10-15|Entry created (batch 4). Resolves stack reference from Derek (MPMD).